OVERVIEW

Expert Perspectives on Preventing HPV in Pediatric Patients is organized by Healio, Vindico Medical Education.

This enduring material is approved for 1 year from the date of original release, June 30, 2022, to June 29, 2023.

Activity Description:
Human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States and a primary cause of cervical, oropharyngeal, and anogenital cancers. An estimated 14 million new cases are diagnosed annually in the US, with most new infections occurring in teens and young adults. HPV-related, noncervical cancers are on the rise in the United States, especially in males. Although safe and effective HPV vaccines are available to protect against infection and subsequent disease, vaccination rates remain suboptimal. In this interactive educational program, experts will consider the burden and stigma associated with HPV, provide guidance on identifying key candidates for vaccination, and discuss counseling and communication strategies to improve vaccine uptake. The faculty will also review the recommended vaccination schedules and HPV vaccine efficacy data.

Learning Objectives:
Upon successful completion of this activity, participants should be better able to:
• Discuss the burden and stigma typically associated with HPV.
• Identify appropriate pediatric candidates for HPV vaccination.
• Implement appropriate counseling and communication strategies to caregivers of pediatric patients to improve HPV vaccine uptake.